Free company check · Companies House, live

GREY WOLF THERAPEUTICS LIMITED

active
Company number 10989365
Incorporated
29 Sept 2017
Age
8 years
Company type
Private limited
Registered in
Abingdon
Active directors
11
Sector
Scientific R&D · SIC 72110
Accounts due
30 Sept 2027
Confirmation due
10 Nov 2026
Registered office
99 Park Drive, Abingdon, OX14 4RY
The full check · £9 one-off

This page is the public half. The full check adds sanctions lists (OFSI, OFAC, UN), the FCA register, Gazette and court records, disqualifications, each director's other companies and an adverse-media sweep, read into a plain-English verdict. No account; emailed in minutes.

Tero is reading the filings: share allotments, the shareholder list, the latest accounts, the disqualified-directors register…
Directors
Paul John Grattan StainerFind on LinkedIn ↗
secretary · since 1 May 2025
Brenton Karl AhrensFind on LinkedIn ↗
director · since 29 Mar 2018
American · born Mar 1963
Thierry HercendFind on LinkedIn ↗
director · since 29 Mar 2018
French · born Mar 1952
director · since 29 Sept 2017
British · born Apr 1982
Allan Patrick MarchingtonFind on LinkedIn ↗
director · since 2 Mar 2026
British · born Jul 1966
Thomas David MccarthyFind on LinkedIn ↗
director · since 29 Sept 2017
Australian · born Jun 1967
director · since 16 Apr 2026
British · born Oct 1954
Rabab NasrallahFind on LinkedIn ↗
director · since 23 Dec 2022
Australian · born Aug 1986

4 officers resigned over the company's life.

Opens a LinkedIn name search. We cannot confirm identities: check the profile mentions this company before relying on it, and if nothing comes up the person may simply not be on LinkedIn.

Control · PSC register

No active persons with significant control registered.

Holdings under 25% do not appear on this register; the cap table above (when filed) shows them.

Recent filings
AA26 Aug 2026
accounts with accounts type small
SH0120 Aug 2026
capital allotment sharesNew share allotment - a round may have closed; your % may have changed.
SH0617 Aug 2026
capital cancellation shares
SH0617 Aug 2026
capital cancellation shares
SH0617 Aug 2026
capital cancellation shares
SH0317 Aug 2026
capital return purchase own shares
That was the registers. Now the rest.

Tero's full due-diligence report reads the pitch deck, the market, the competition, the founders' track records and the digital footprint, cross-checked against 12+ official sources, with an adversarial pass before anything is stated.

Compiled from the Companies House public registers at the time shown; verify against the live register before acting. Register name matches are not identity confirmations. Tero is software. We are not a fund, we do not hold client money, and we do not provide investment advice or personal recommendations. Information, not tax or investment advice. Capital at risk.